Oral Arguments Held In Patent Dispute Over Zolmitriptan Nasal Spray

WASHINGTON, D.C. — A patent infringement defendant at oral arguments on April 5 told the Federal Circuit U.S. Court of Appeals that a Delaware federal judge committed reversible errors of law...

Already a subscriber? Click here to view full article